Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Vor Biopharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
VOR
Nasdaq
8731
https://www.vorbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Vor Biopharma Inc
Why You Shouldn't Bet Against Vor Biopharma (VOR) Stock
- Apr 4th, 2024 12:32 pm
Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation
- Mar 29th, 2024 10:09 am
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
- Mar 20th, 2024 8:05 pm
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Mar 5th, 2024 9:01 pm
Vor Bio to Participate in Upcoming Investor Conferences
- Mar 4th, 2024 1:00 pm
Institutions own 36% of Vor Biopharma Inc. (NASDAQ:VOR) shares but private equity firms control 43% of the company
- Feb 17th, 2024 12:17 pm
2 “Strong Buy” Penny Stocks That Could Rally All the Way to $10 (or More)
- Feb 15th, 2024 7:56 pm
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 7th, 2024 1:00 pm
Vor Bio (VOR) Up on Positive Update From AML Cell Therapy Study
- Jan 19th, 2024 1:22 pm
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
- Jan 17th, 2024 9:01 pm
Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference
- Nov 9th, 2023 9:01 pm
Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update
- Nov 7th, 2023 9:05 pm
Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T Platform
- Nov 2nd, 2023 1:01 pm
Will Vor Biopharma (NASDAQ:VOR) Spend Its Cash Wisely?
- Sep 27th, 2023 10:04 am
Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update
- Aug 10th, 2023 8:05 pm
Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients
- Jun 9th, 2023 8:03 pm
Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform
- Jun 9th, 2023 11:30 am
Vor Bio to Participate in the Goldman Sachs Healthcare Conference
- Jun 5th, 2023 12:00 pm
Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update
- May 11th, 2023 8:05 pm
We Think Vor Biopharma (NASDAQ:VOR) Can Afford To Drive Business Growth
- Apr 19th, 2023 6:42 pm
Scroll